This is the bit I like “Phase 1 is planned to be complete by 30 June 2019. The aim will be to have an agreed approach for commercial release and model for large-scale delivery in place by July 2019.”
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025